XML 21 R8.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 3 Months Ended 12 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
Operating activities:      
Net income $ 88,905 $ 112,246  
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 91,218 87,741  
Accretion of debt premium and discount, net (728) (716)  
Deferred financing cost amortization 1,796 1,755  
Accretion of above- and below-market leases, net (2,408) (3,389)  
Tenant inducement amortization and other 731 804  
Impairment of real estate assets 0 1,100  
Gain on sale of real estate assets (15,142) (48,468)  
Equity based compensation 3,359 4,191  
Changes in operating assets and liabilities:      
Receivables, net 28,639 15,578  
Deferred charges and prepaid expenses (9,020) (11,815)  
Other assets (1,222) (215)  
Accounts payable, accrued expenses and other liabilities (57,612) (23,758)  
Net cash provided by operating activities 128,516 135,054  
Investing activities:      
Improvements to and investments in real estate assets (76,861) (72,376)  
Proceeds from sales of real estate assets 67,237 119,659  
Purchase of marketable securities (4,366) (6,162)  
Proceeds from sale of marketable securities 4,811 7,364  
Net cash provided by (used in) investing activities (9,179) 48,485  
Financing activities:      
Repayment of borrowings under unsecured revolving credit facility (98,500) (195,000)  
Proceeds from borrowings under unsecured revolving credit facility 80,000 117,000  
Proceeds from unsecured notes 399,264 0  
Deferred financing and debt extinguishment costs (3,766) (60)  
Distributions to common stockholders (83,866) (80,080)  
Repurchases of common shares in conjunction with equity award plans (12,962) (11,229)  
Net cash provided by (used in) financing activities 280,170 (169,369)  
Net change in cash, cash equivalents and restricted cash 399,507 14,170  
Cash, cash equivalents and restricted cash at beginning of period 18,904 21,259 $ 21,259
Cash, cash equivalents and restricted cash at end of period 418,411 35,429 18,904
Reconciliation to consolidated balance sheets:      
Cash and cash equivalents 407,105 3,430 866
Restricted cash 11,306 31,999 18,038
Cash, cash equivalents and restricted cash at end of period 418,411 35,429 18,904
Supplemental disclosure of cash flow information:      
Cash paid for interest, net of amount capitalized of $920 and $949 49,384 50,250  
Brixmor Operating Partnership LP      
Operating activities:      
Net income 88,905 112,246  
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 91,218 87,741  
Accretion of debt premium and discount, net (728) (716)  
Deferred financing cost amortization 1,796 1,755  
Accretion of above- and below-market leases, net (2,408) (3,389)  
Tenant inducement amortization and other 731 804  
Impairment of real estate assets 0 1,100  
Gain on sale of real estate assets (15,142) (48,468)  
Equity based compensation 3,359 4,191  
Changes in operating assets and liabilities:      
Receivables, net 28,639 15,578  
Deferred charges and prepaid expenses (9,020) (11,815)  
Other assets (1,222) (215)  
Accounts payable, accrued expenses and other liabilities (57,612) (23,758)  
Net cash provided by operating activities 128,516 135,054  
Investing activities:      
Improvements to and investments in real estate assets (76,861) (72,376)  
Proceeds from sales of real estate assets 67,237 119,659  
Purchase of marketable securities (4,366) (6,162)  
Proceeds from sale of marketable securities 4,811 7,364  
Net cash provided by (used in) investing activities (9,179) 48,485  
Financing activities:      
Repayment of borrowings under unsecured revolving credit facility (98,500) (195,000)  
Proceeds from borrowings under unsecured revolving credit facility 80,000 117,000  
Proceeds from unsecured notes 399,264 0  
Deferred financing and debt extinguishment costs (3,766) (60)  
Partner distributions and repurchases of OP Units (97,423) (90,382)  
Net cash provided by (used in) financing activities 279,575 (168,442)  
Net change in cash, cash equivalents and restricted cash 398,912 15,097  
Cash, cash equivalents and restricted cash at beginning of period 18,904 20,332 20,332
Cash, cash equivalents and restricted cash at end of period 417,816 35,429 18,904
Reconciliation to consolidated balance sheets:      
Cash and cash equivalents 406,510 3,430 866
Restricted cash 11,306 31,999 18,038
Cash, cash equivalents and restricted cash at end of period 417,816 35,429 $ 18,904
Supplemental disclosure of cash flow information:      
Cash paid for interest, net of amount capitalized of $920 and $949 $ 49,384 $ 50,250